Company · CIK 1325279

# CELLCYTE GENETICS CORP

| CIK | [1325279](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001325279) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | WA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2008-05-15 |

## Offerings

 0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2007-07-17 | [424B1](https://www.sec.gov/Archives/edgar/data/1325279/000118374007000465/0001183740-07-000465-index.htm) Final prospectus | 333-144203 | 0001183740-07-000465 |
| 2007-07-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1325279/999999999507002772/9999999995-07-002772-index.htm) Declared effective | 333-144203 | 9999999995-07-002772 |

[All filings of this company](https://equitycapital.markets/filings?cik=1325279) · [CSV](https://equitycapital.markets/filings.csv?cik=1325279)

---
Source page: https://equitycapital.markets/company/1325279 · Data: U.S. SEC EDGAR · CC BY 4.0